Literature DB >> 21466629

Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus.

Gary E Sander1, Thomas D Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21466629      PMCID： PMC8673217          DOI： 10.1111/j.1751-7176.2011.00454.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  29 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.

Authors:  Joseph J Torre; Zachary T Bloomgarden; Richard A Dickey; Michael J Hogan; John J Janick; Sathya G Jyothinagaram; Helmy M Siragy
Journal:  Endocr Pract       Date:  2006 Mar-Apr       Impact factor: 3.443

3.  The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.

Authors: 
Journal:  JAMA       Date:  1981-11-06       Impact factor: 56.272

4.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Authors:  L Hansson; T Hedner; P Lund-Johansen; S E Kjeldsen; L H Lindholm; J O Syvertsen; J Lanke; U de Faire; B Dahlöf; B E Karlberg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

7.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

8.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Authors:  George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Rosemary Oakes; Mary Ann Lukas; Karen M Anderson; David S H Bell
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

9.  Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.

Authors:  Turgay Celik; Atila Iyisoy; Hurkan Kursaklioglu; Ejder Kardesoglu; Selim Kilic; Hasan Turhan; M Ilker Yilmaz; Omer Ozcan; Halil Yaman; Ersoy Isik; Francesco Fici
Journal:  J Hypertens       Date:  2006-03       Impact factor: 4.844

10.  Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.

Authors:  J R Cockcroft; P J Chowienczyk; S E Brett; C P Chen; A G Dupont; L Van Nueten; S J Wooding; J M Ritter
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030
View more
  5 in total

Review 1.  Beta-blockers for hypertension.

Authors:  Charles S Wiysonge; Hazel A Bradley; Jimmy Volmink; Bongani M Mayosi; Lionel H Opie
Journal:  Cochrane Database Syst Rev       Date:  2017-01-20

2.  Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.

Authors:  Jennifer A Hirst; Andrew J Farmer; Benjamin G Feakins; Jeffrey K Aronson; Richard J Stevens
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

3.  Drug-induced diabetes type 2: In silico study involving class B GPCRs.

Authors:  Dorota Latek; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

4.  Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking.

Authors:  Pawel Pasznik; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek; Dorota Latek
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

5.  Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.

Authors:  Prakash Deedwania; John Shea; Wei Chen; Lillian Brener
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.